Citation only
via Europe PMC
Premature immune aging in obesity: a testable framework linking immunosenescence, metaflammation, and multiorgan dysfunction.
Sulaiman SH, Omer RA, Muhammad HY, Qadir AM, Barzani HAH.
Immunologic research · 2026
Epigenetic alterations
Mitochondrial dysfunction
Cellular senescence
Altered intercellular communication
Chronic inflammation
Exercise
Human
Review
Abstract
Obesity is a chronic immunometabolic disorder associated with alterations in biological aging pathways and increased risks of type 2 diabetes mellitus, cardiovascular disease, metabolic dysfunction-associated steatotic liver disease, chronic kidney disease, neurodegeneration, and cancer. Obesity and chronological aging share several characteristics, including low-grade inflammation, cellular senescence(definition), mitochondrial dysfunction(definition), oxidative stress, epigenetic alterations, and immune remodeling. However, these similarities do not necessarily establish accelerated biological immune aging. This review critically evaluates obesity-associated immunosenescence, metaflammation, and multiorgan dysfunction by examining supporting and conflicting findings, alternative explanations, methodological limitations, and therapeutic evidence. Although experimental and observational studies report alterations in lymphocyte differentiation, innate immune function, inflammatory signaling, and selected biological-age markers, these findings are not uniformly observed across immune-cell populations, tissues, or metabolic phenotypes. Metabolically healthy obesity, tissue-dependent epigenetic aging, and differences between human and animal findings challenge the interpretation of obesity as a universal accelerator of immunosenescence. Furthermore, chronological age, cytomegalovirus infection, sex-related differences, adiposity distribution, and metabolic comorbidities complicate attributing immune alterations specifically to obesity. The proposed immunosenescence-metaflammation-multiorgan dysfunction framework therefore remains a testable mechanistic hypothesis rather than an established causal pathway. Although immune-cell phenotypes, epigenetic clocks, inflammatory mediators, and multi-omics signatures may help characterize obesity-associated immune dysfunction, their specificity, longitudinal validity, and clinical utility remain insufficiently established. Nutritional interventions, exercise, bariatric surgery, and pharmacological treatments can improve selected metabolic and inflammatory outcomes, but these improvements do not necessarily demonstrate sustained reversal of biological immune aging. By critically comparing supportive evidence with contradictory observations and unresolved causal relationships, this review identifies the principal limitations of current mechanistic, biomarker, and therapeutic research. Future studies should prioritize longitudinal immune profiling, direct functional assessment, tissue- and sex-specific analyses, causal validation, and controlled interventions incorporating validated immune-aging endpoints to determine whether premature immune aging is a measurable and therapeutically modifiable consequence of obesity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s12026-026-09877-w
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
SH, S., RA, O., HY, M., AM, Q., & HAH., B. (2026). Premature immune aging in obesity: a testable framework linking immunosenescence, metaflammation, and multiorgan dysfunction. <em>Immunologic research</em>. https://doi.org/10.1007/s12026-026-09877-w
Vancouver
SH S, RA O, HY M, AM Q, HAH. B. Premature immune aging in obesity: a testable framework linking immunosenescence, metaflammation, and multiorgan dysfunction. Immunologic research. 2026. doi:10.1007/s12026-026-09877-w.
BibTeX
@article{sulaiman2026Premat,
title = {Premature immune aging in obesity: a testable framework linking immunosenescence, metaflammation, and multiorgan dysfunction.},
author = {Sulaiman SH and Omer RA and Muhammad HY and Qadir AM and Barzani HAH.},
journal = {Immunologic research},
year = {2026},
doi = {10.1007/s12026-026-09877-w},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in aging 2026
Open access · OA
Epigenetic aging in the tumor microenvironment: mechanisms and implications for immunotherapy.
Experimental Gerontology 2026
Open access · CC-BY
Immunosenescence, inflammaging, and metabolic disease: A geroscience perspective on mechanisms and links
Neuroscience & Biobehavioral Reviews 2026
Open access · CC-BY
Sleep-related Alzheimer’s disease vulnerability in aging: A muscle-metabolic perspective
Diabetes, metabolic syndrome and obesity : targets and therapy 2026
Open access · OA
Mitochondrial Dysfunction in Type 2 Diabetes and Metabolic Syndrome: Mechanisms, Biomarkers, and Emerging Therapies.
Ageing research reviews 2026
Citation only
Multikingdom gut microbiome and immune aging: A host-microbial signaling perspective.
African Journal of Biomedical Research 2026
Open access · CC-BY